Literature DB >> 89732

Human B cell function in a polyclonally induced plaque forming cell system. Cell triggering and immunoregulation.

A S Fauci.   

Abstract

The use of a sensitive PFC assay against a specific antigenic determinant (SRBC) following polyclonal triggering of human lymphocytes has provided a unique insight into the complex mechanisms of triggering of human B cells. The system is under the strict regulation of a delicate balance between helper and suppressor influences reflecting in certain circumstances the activity of distinct subsets of immunoregulatory cells. Lymphoid cells in certain diseases characterized by disordered immunoregulation, when as system, may in effect be manifesting an abnormal expression of immunoregulatory mechanisms operable in normal immune responses. In vivo activation of lymphoid cells by PBAs may have an important role in disease states as well as in the subsequent in vitro expression of B cell function. Furthermore, it is quite possible that under certain circumstances some B cell responses which appear to be purely antigen-specific may be reflections of synergy between PBA substances and specific antigen. The use of PBAs as probes and sensitive PVC systems as assays has already proven fruitful in the dissection of the complex mechanisms of nonspecific B cell triggering in man and may indeed ultimately lead to an understanding of the mechanisms of specificity of immune reactivity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89732     DOI: 10.1111/j.1600-065x.1979.tb00274.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  20 in total

1.  Polyclonal and antigen-specific B-cell responses in patients with common variable immunodeficiency.

Authors:  S G Pahwa; M K Hoffman; R N Pahwa; R A Good
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

2.  Interaction of pokeweed mitogen with monocytes in the activation of human lymphocytes.

Authors:  H C Stevenson; P J Miller; M J Waxdal; B F Haynes; C A Thomas; A S Fauci
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

3.  Immunoregulatory T-cell dysfunction in polyclonal gammopathy.

Authors:  R A Robinson; N L Abdou; N I Abdou
Journal:  J Clin Immunol       Date:  1981-01       Impact factor: 8.317

4.  Polyclonal B-cell activation induced by extracts of Gram-negative bacteria isolated from periodontally diseased sites.

Authors:  P H Bick; A B Carpenter; L V Holdeman; G A Miller; R R Ranney; K G Palcanis; J G Tew
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

5.  Polyclonal human T lymphocyte activation results in the secondary functional activation of the human B lymphocyte.

Authors:  A G Bird; L Hammarström; C I Smith; S Britton
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

6.  Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation.

Authors:  D J Volkman; H C Lane; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

7.  In vitro idiotypic suppression of chronic lymphocytic leukemia lymphocytes secreting monoclonal immunoglobulin M anti-sheep erythrocyte antibody.

Authors:  C A Bona; A S Fauci
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

8.  Nonspecific induction of immunoglobulin M antibodies to periodontal disease-associated microorganisms after polyclonal human B-lymphocyte activation by Fusobacterium nucleatum.

Authors:  D F Mangan; T Won; D E Lopatin
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.

Authors:  J Laurence; A B Gottlieb; H G Kunkel
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

10.  Klebsiella pneumoniae stimulate highly purified human blood B cells to mature into plaque forming cells without prior proliferation.

Authors:  W L Gross; A Rucks
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.